Digest Network Come funziona
Network
/
Società
Se
Non verificato

Sensorion

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

54 comunicati stampa

Guarda tutti i comunicati
28/10/2026
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Eventi
Sensorion Announces its Participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress
Fonte
Sensorion
Emittente
Business Wire
1.00
0
23/09/2026
Mercato azionario
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Sensorion Reports 2026 Half-Year Results, Provides Corporate Update and Announces Availability of Half-Year Report
Fonte
Sensorion
Emittente
Business Wire
1.00
0
18/09/2026
Web e Social Network
Industria
Eventi
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Sensorion Announces Connection Details for its SENS-601 Program Day on September 22, 2026
Fonte
Sensorion
Emittente
Business Wire
1.00
0
16/09/2026
Biotecnologia
Sanità
Farmaceutica
Salute
Sensorion Announces Confidential Submission of Draft Registration Statement to the SEC for Potential U.S. Initial Public Offering
Fonte
Sensorion
Emittente
Business Wire
1.00
0
15/09/2026
Finanza
Salute
Vetrine/Shopping
Biotecnologia
Farmaceutica
Sensorion Announces the Completion of Its Reverse Share Split
Fonte
Sensorion
Emittente
Business Wire
1.00
0
03/09/2026
Industria
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Sensorion Announces Approval of Clinical Trial Application in France for SENS-601, Its Investigational Gene Therapy for the Treatment of GJB2-Related Hearing Loss
Fonte
Sensorion
Emittente
Business Wire
1.00
0
29/07/2026
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Finanza
Sensorion Announces a Reverse Share Split of its Shares
Fonte
Sensorion
Emittente
Business Wire
1.00
0
10/06/2026
Scienza
Farmaceutica
Sanità
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Industria
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
Fonte
Sensorion
Emittente
Business Wire
1.00
0
10/06/2026
Scienza
Farmaceutica
Sanità
Salute
Igiene alimentare
Biotecnologia
Medicina - Varie
Industria
Sensorion Achieves Key Regulatory Milestones for SENS-601 for GJB2-related Hearing Loss and Selects Program as Lead Gene Therapy Candidate
Fonte
Sensorion
Emittente
Business Wire
1.00
0
18/05/2026
Salute
Biotecnologia
Medicina - Varie
Scienza
Farmaceutica
Mercato del lavoro
Sensorion Appoints Fred Chereau as Chief Executive Officer
Fonte
Sensorion
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0